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Abstract Breast cancer patients often experience adverse
physical side effects of medical treatments. According to the
biobehavioral model of cancer stress and disease, life stress
during diagnosis and treatment may negatively influence the
trajectory of women’s physical health-related adjustment to
breast cancer. This longitudinal study examined chronic and
episodic stress as predictors of bothersome physical symp-
toms during the year after breast cancer diagnosis. Women
diagnosed with breast cancer in the previous 4 months
(N = 460) completed a life stress interview for contextual
assessment of chronic and episodic stress severity at study
entry and 9 months later. Physical symptom bother (e.g.,
pain, fatigue) was measured at study entry, every 6 weeks
through 6 months, and at nine and 12 months. In multilevel
structural equation modeling (MSEM) analyses, both
chronic stress and episodic stress occurring shortly after
diagnosis predicted greater physical symptom bother over
the study period. Episodic stress reported to have occurred
prior to diagnosis did not predict symptom bother in MSEM
analyses, and the interaction between chronic and episodic
stress on symptom bother was not significant. Results sug-
gest that ongoing chronic stress and episodic stress occurring
shortly after breast cancer diagnosis are important predictors
of bothersome symptoms during and after cancer treatment.
Screening for chronic stress and recent stressful life events in
the months following diagnosis may help to identify breast
cancer patients at risk for persistent and bothersome physical
symptoms. Interventions to prevent or ameliorate treatment-
related physical symptoms may confer added benefit by
addressing ongoing non-cancer-related stress in women’s
lives.
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Introduction
Women with breast cancer typically undergo intensive
medical treatments, which can include surgery, radiation
therapy, chemotherapy, hormonal therapy, and/or biologic
therapy. These treatments often cause adverse physical side
effects such as fatigue, pain, and nausea (e.g., Bower,
2008; Shapiro & Recht, 2001). Although most women with
breast cancer adjust well physically and psychologically
over the long term (Ganz et al., 2011), some experience
substantial and long-lasting physical symptoms that inter-
fere with daily functioning and quality of life (Bower,
2008; Helgeson et al., 2004). Nearly two-thirds of women
with breast cancer report post-surgical pain (Davies, 2013),
and between 30 and 100% experience sexual difficulties
(DeSimone et al., 2014). One-fourth of breast cancer
patients experience significant fatigue for years after
treatment (Bower, 2014). Women who report greater can-
cer-related physical symptoms during treatment are at
higher risk for later cancer-related distress, intrusive
thoughts, and general distress (Jim et al., 2007). Given the
high prevalence and persistence of physical symptoms
experienced by women with breast cancer and their long-
term implications for health and well-being, early identi-
fication of key predictors of bothersome physical symp-
toms is crucial in order to target at-risk women for
prevention and timely intervention. Prospective research
investigating psychosocial predictors of bothersome phys-
ical symptoms associated with breast cancer, however, is
limited. The current study examined contextually-rated
chronic and episodic life stress occurring prior to and
shortly after diagnosis as early risk factors for persistent
physical symptoms during the year after breast cancer
diagnosis.
In addition to facing a diagnosis of breast cancer,
women often experience ongoing, chronic stress in other
life domains (e.g., financial insecurity, relationship prob-
lems; Vickberg, 2003) as well as stressful life events
unrelated to their cancer diagnosis or treatment (e.g., death
or illness of a loved one; Golden-Kreutz & Andersen,
2004). Adjustment to a prominent stressor such as breast
cancer is best understood in the context in which it occurs
(Revenson, 2003) and according to the biobehavioral
model of cancer stress and disease (Andersen et al., 1994;
Lutgendorf & Andersen, 2015), life stress during the pro-
cess of cancer diagnosis and treatment can contribute to
deterioration in quality of life. Consistent with this model,
empirical evidence demonstrates that non-cancer-related
stressful life events (Burgess et al., 2005; Golden-Kreutz &
Andersen, 2004; Golden-Kreutz et al., 2005; Grassi et al.,
1997; Kornblith et al., 2001) and perceived overall stress
(Golden-Kreutz & Andersen, 2004; Golden-Kreutz et al.,
2005) are significant predictors of poorer psychological
adjustment to breast cancer. In one longitudinal study,
however, stressful life events did not predict change in
psychological adjustment (i.e., depressive symptoms, can-
cer-specific distress, vitality, perceived personal growth)
during the year after breast cancer treatment completion
(Low et al., 2006). Notably, with the exception of Burgess
et al. (2005), the above studies employed subjective ratings
of perceived overall stress and/or checklist measures to
assess stressful life events despite research suggesting that
interview-based contextual (i.e., based on objective fea-
tures of the stress given the context in which it occurs)
measurement of severity of threat from acute life events
and ongoing difficulties more effectively predicts out-
comes, facilitates more accurate recall of events, and is less
subject to participant bias based on current mood (Ham-
men, 2005).
Furthermore, research examining life stress as a pre-
dictor of bothersome physical symptoms in breast cancer is
limited. A longitudinal study of women who had recently
undergone breast cancer surgery found that perceived
overall stress, perceived cancer-related stress, and stressful
life events reported on a checklist measure as occurring
during the year prior to diagnosis predicted poorer physical
quality of life during adjuvant treatment and after treatment
completion (Golden-Kreutz et al., 2005). The current study
expands upon previous research by prospectively examin-
ing the relationships between contextually-rated chronic
stress (i.e., ongoing, taxing experiences) and episodic stress
(i.e., discrete life events that are likely to tax or exceed
personal resources) and bothersome physical symptoms
during the year after breast cancer diagnosis. Henceforth,
‘‘stress’’ in this report refers to the context-based severity
of stressful life events (episodic) and difficulties (chronic).
If stress occurring within the first months after diagnosis
predicts bothersome symptoms months later, careful
interpretation of this finding is warranted. Specifically, it is
useful to ask whether early stress has an enduring impact or
whether women who experience heightened stress shortly
after diagnosis continue to experience heightened stress
during and after treatment, which could then contempora-
neously affect physical symptoms. As a secondary aim, the
current study examined this question by assessing corre-
lations between stress ratings at study entry (within
4 months of diagnosis) and 9 months later (approximately
1 year after diagnosis).
Hypotheses were that higher levels of both chronic and
episodic stress, compared with lower stress, would predict
greater and more persistent physical symptom bother over
time, and that proximal episodic stress, occurring in the
first months following breast cancer diagnosis, would have
a stronger relation to symptom bother than episodic stress
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reported to have occurred in the months prior to diagnosis.
Furthermore, chronic stress was expected to be a stronger
predictor of persistent symptom bother than episodic stress,
because the latter is more likely to resolve (Diener et al.,
2006). Accordingly, chronic stress at study entry was
expected to be highly correlated with chronic stress 1 year
after diagnosis, whereas episodic stress at study entry was
expected to be weakly correlated with episodic stress
1 year post-diagnosis. Finally, an interaction between
chronic and episodic stress was predicted such that high
levels of episodic stress in the context of high chronic
stress would predict particularly high symptom bother,
reflecting a cumulative effect (Brown & Harris, 1978).
Method
Participants
The current study involves secondary analysis of data from
a longitudinal study examining psychosocial and cancer-
related predictors of depression and other outcomes among
recently diagnosed breast cancer patients (Bauer et al.,
2016; Marroquı´n et al., 2016; Stanton et al., 2015). Of 823
women approached to participate, 61 were ineligible (8%).
Of the 762 eligible women, 302 (40%) declined to partic-
ipate or were unreachable by telephone, and 460 (60%)
consented and completed an initial in-person assessment
within 4 months of breast cancer diagnosis. Participants
completed telephone assessments every 6 weeks through
6 months after the initial assessment, another in-person
assessment at 9 months, and a telephone assessment at
12 months. Overall attrition was 19% at study end (Stanton
et al., 2015).
Procedure
The relevant Institutional Review Boards approved all
study procedures. Women were recruited from oncology
clinics in the greater Los Angeles, California area and in
Tucson, Arizona. Within scheduling constraints, consecu-
tive newly diagnosed or newly recurrent breast cancer
patients were informed of the study by clinic or research
staff following a standard verbal script. With verbal con-
sent, study personnel contacted interested women to pro-
vide information and screen for eligibility: (1) new or
recurrent diagnosis of invasive breast cancer within
4 months prior to the initial assessment, (2) at least
21 years of age, and (3) ability to complete assessments in
English. Any standard medical treatment for cancer (i.e.,
surgery, chemotherapy, radiotherapy, neoadjuvant
chemotherapy, endocrine therapy) and any additional
medications were allowed. Exclusion criteria were current
or past bipolar disorder, schizophrenia, schizoaffective
disorder, or cognitive disorder (e.g., dementia), and current
suicidality.
The initial assessment, conducted by trained post-bac-
calaureate level research staff, required 3 h and was com-
pleted in a private room at the treating oncology center or
at women’s homes. After giving informed consent, par-
ticipants completed self-report measures and a semi-
structured interview. Women began by completing self-
report measures in interview format and were given the
option to complete the remaining items independently on
the computer with the interviewer present.
During follow-up telephone assessments, which lasted
approximately 30 min each, participants responded verbally
to items. The in-person assessment at 9 months was con-
ducted in a similar fashion to the initial assessment and
required approximately 2 h. Women were compensated $60
for in-person assessments and $30 for telephone assessments.
Measures
Demographic and cancer-related variables
Age, marital status, ethnicity, household income, educa-
tion, employment, subjective social status (Kilpatrick &
Cantril, 1960), body mass index, and number of comorbid
physical diseases (Groll et al., 2005) were collected by self-
report at study entry. Cancer-related variables (cancer
stage, chemotherapy, surgery, radiation therapy, herceptin
use, endocrine therapy use) were reported at study entry
and each subsequent assessment. Cancer stage was
obtained through medical chart review; self-reported can-
cer stage was used when the chart was unavailable
(n = 39).
Stress
The UCLA Life Stress Interview (LSI; Hammen, 1991a)
was administered at study entry and 9 months to assess
contextual severity of chronic and episodic life stress. The
LSI is a psychometrically reliable and well-validated semi-
structured interview to evaluate stressful life events, as well
as chronic stress in nine life domains (i.e., close friend-
ships, romantic relationships, family of origin, children,
finances, work, academics, health of self, health of family;
Hammen et al., 2009; Daley et al., 2000). The ‘‘health of
self’’ domain did not include assessment of cancer-related
content. At study entry, chronic and episodic stress were
retrospectively reported for the 6 months prior to breast
cancer diagnosis (pre-diagnosis) and from diagnosis to
study entry (post-diagnosis). At 9 months, chronic and
episodic stress since study entry were assessed.
J Behav Med (2017) 40:875–885 877
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Chronic stress As per protocol (Hammen, 1991b), inter-
viewers assessed chronic stress by querying typical con-
ditions in each life domain and then rating each domain on
a five-point scale in increments of .5, ranging from 1 (ex-
ceptionally positive circumstances) to 5 (extremely adverse
circumstances) and using descriptive behavioral anchors.
For example, for the domain of romantic relationships, a
score of 2 represents a stable, positive relationship (close,
confiding, trusting), and 4 represents a deteriorating rela-
tionship or severe problems in the relationship (unstable,
poor conflict resolution). Study entry chronic stress ratings
were averaged across all domains to yield a total chronic
stress score (Hammen et al., 2009). Previous research has
demonstrated the stability of LSI chronic stress ratings
(e.g., Daley et al., 2000). Because study entry chronic
stress ratings for pre- and post-diagnosis were highly cor-
related (r = .92, p\ .001), they were averaged and the
overall chronic stress rating was used for the initial score,
with higher ratings indicating more chronic stress. A sep-
arate score was calculated for total chronic stress at
9 months.
Episodic stress Participants were asked in the study entry
interview whether ‘‘any particular events had occurred’’ in
the 6 months prior to breast cancer diagnosis (pre-diag-
nosis) or since diagnosis (post-diagnosis) in each of the
nine domains, as well as whether any other events not
captured by the queried domains (e.g., auto accident) had
occurred during the same time periods. At 9 months, par-
ticipants were asked about events that had occurred since
study entry. Interviewers provided examples of events in
each domain. For instance, interviewers asked whether any
major arguments had occurred when assessing episodic
stressors in interpersonal domains. Interviewers gathered
details about the context in which each reported event
occurred (e.g., what happened, consequences, controlla-
bility) in order to assess the severity of the event given its
unique features for that individual’s life. Normative cancer-
related events (e.g., surgery, change in treatment plan)
were not included.
Interviewers then presented each event in narrative form
to a coding team of at least two trained post-baccalaureate
level research staff who were blind to the participant’s
reactions to events. The team, excluding the interviewer,
rated the impact of each event on a severity scale ranging
from 1 (none) to 5 (extremely severe) in increments of .5
based on the severity of impact on the life course of a
typical individual under identical circumstances. Ratings
were reached by consensus. Separate study entry episodic
stress ratings for pre- and post-diagnosis were calculated by
summing the impact ratings of all events with at least
moderate impact or higher, scored at 2 or above (Hammen
et al., 2009; Rudolph et al., 2000). Separate study entry
pre- and post-diagnosis ratings were retained for separate
analyses because they were not significantly correlated. A
third score was calculated for episodic stress at 9 months.
Higher ratings indicate higher severity and/or more fre-
quent occurrence of episodic stressors.
Physical symptom bother
Measured at each assessment, bother from physical
symptoms was assessed using the 25-item Breast Cancer
Prevention Trial Symptom Scales (BCPT; Stanton et al.,
2005). This measure was developed specifically to assess
bother from common cancer and treatment-related side
effects and symptoms among women diagnosed with breast
cancer. Previous studies have established that the BCPT
has discriminant validity, as evidenced by modest negative
correlations with health-related quality of life, and is dis-
tinct from mood (Cella et al., 2008). Although the BCPT
was correlated with depressive symptoms (r = .43,
p\ .05), only the cognitive symptom subscale was sig-
nificantly correlated with depression (r = .46, p\ .05).
Due to the prevalence and impact of fatigue and sexual
problems among breast cancer patients (Bower, 2014;
DeSimone et al., 2014), the BCPT was expanded to include
four items for those problems, for a total of 10 subscales
(i.e., hot flashes, nausea, bladder control, pain, cognitive
problems, weight problems, arm problems, vaginal symp-
toms, fatigue, sexual problems). Respondents indicated
how much they had been bothered by each symptom during
the past 4 weeks on a scale ranging from 0 (not at all) to 4
(extremely). The mean score on the expanded BCPT (av-
erage of all items) was used; higher scores indicate greater
symptom bother. Internal consistency reliability was high
at all assessments (a = .83 to .87).
Data analysis
Descriptive statistics were calculated for all study vari-
ables. Pearson correlation coefficients between predictors
(study entry chronic stress, episodic stress pre- and post-
diagnosis) and the outcome variable (BCPT) at each
assessment were calculated. Correlations between stress
variables at study entry and 9 months were calculated to
examine stability of stress ratings over time.
Due to the hierarchical nature of the data, with repeated
assessments (Level 1) nested within participants (Level 2),
multilevel structural equation modeling (MSEM; du Toit &
du Toit, 2008; Muthe´n & Muthe´n, 2012) was conducted in
Mplus version 7.3. MSEM allows for testing effects of
time-varying (measured at multiple time points) and time-
invariant (measured at one time point) predictors on a time-
878 J Behav Med (2017) 40:875–885
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varying outcome. The growth models included a random
intercept to characterize variability between participants in
symptom bother at study entry, as well as random linear
and quadratic terms. Models were estimated using full
information maximum likelihood (Enders & Bandalos,
2001), which includes cases with missing data on predic-
tors. Missingness on predictors was minimal (3.9% for all
predictors). Two-tailed significance tests were used
throughout.
An unconditional model without predictors or covariates
was estimated to examine the overall symptom trajectory
over the study period. To test random intercept, linear and
quadratic terms, likelihood ratio tests (Hayes, 2006) were
conducted. All significant variance and covariance com-
ponents were retained in subsequent models.
Covariates were selected using a combined theoretical
and empirical approach (see Bauer et al., 2016). First,
potential covariates were selected based on their theoretical
relationship with the outcome. Then, MSEM was used to
examine the univariate relation of each sociodemographic
(age, marital status, ethnicity, household income, educa-
tion, employment status, subjective social status, body
mass index, comorbidities, recruitment site) and cancer-
related (cancer stage, chemotherapy, surgery, radiation
therapy, herceptin use, endocrine therapy use, study
assessment at which last medical treatment occurred)
covariate with the trajectory of symptom bother over time.
Quadratic and linear time interactions were tested with
each variable and dropped if not significant (p[ .05). All
variables that were significantly related to the outcome
were retained as covariates in subsequent models, along
with any significant higher-order terms. Finally, we tested a
multivariate model including all potential covariates to
identify variables that were non-significant in univariate
analyses but emerged as significant when examined with
other variables. Variables and higher-order terms that
emerged as newly significant in multivariate analyses were
added to the final covariate model.
Time was centered at the average number of months
since diagnosis at study entry (M = 2.13). Time-varying
treatment status variables (e.g., chemotherapy) were ana-
lyzed as Level 1 variables. Study entry chronic and epi-
sodic stress and other time-invariant variables measured at
study entry only (e.g., income) were analyzed as Level 2
variables.
To examine main effects of study entry chronic stress,
pre-diagnosis episodic stress, and post-diagnosis episodic
stress on symptom bother over time, stress variables with
quadratic and linear time interactions were tested in sepa-
rate models containing covariates. Non-significant higher-
order terms were dropped from the models one by one.
Chronic stress at study entry and pre-diagnosis episodic
stress, as well as chronic stress at study entry and post-
diagnosis episodic stress, were also examined in the same
models to evaluate the unique predictive utility of each
type of stress. Moderation models with interactions
between chronic and episodic stress variables (as well as
their quadratic and linear effects with time) were tested;
episodic stress occurring prior to diagnosis and episodic
stress occurring shortly after diagnosis were tested sepa-
rately with study entry chronic stress. All predictor vari-
ables were centered at the grand mean of each respective
variable. Effect sizes were calculated using proportion of
Level 2 intercept variance, an analog of R2.
Results
Participant characteristics
Women were on average 56 years old (SD = 12.6 years;
range 23–91 years). Over half (55%) had graduated from a
4-year college, 20% had some college education, 21% had
a high school education, and 4% did not graduate from
high school. About one-third (29%) had an annual house-
hold income under $50,000, and another third (36%) had
an income over $100,000. Most (68%) were non-Latina
white, and a substantial minority (19%) were Latina.
Approximately half (52%) were employed, 30% were
retired, and 18% were unemployed. Two-thirds (67%) were
married. On average, women reported 1.8 (SD = 1.9)
physical comorbidities. See Stanton et al. (2015) for
additional details regarding participant characteristics.
Initial assessments occurred, on average, 2.13 months
after women’s breast cancer diagnosis (SD = .81; see
Table 1). The majority were diagnosed with Stage 1 (43%)
or Stage 2 (39%) cancer. At study entry, 60% had under-
gone surgery within the past 6 weeks, and 42% were on
chemotherapy or had completed chemotherapy within the
past 6 weeks.
Descriptive statistics
Means and correlations between study variables are dis-
played in Tables 2 and 3. Chronic stress ratings indicated
that women experienced, on average, mild to moderate
chronic stress across domains at both study entry and
9 months. During the 6 months prior to diagnosis, 42% of
women reported experiencing a significant episodic stres-
sor; 21% reported a significant episodic stressor in the
approximately 2 months between diagnosis and study
entry, and 49% reported a significant episodic stressor from
study entry to 9 months.
Chronic stress in the previous 8 ± .8 months (study
entry) was significantly but weakly correlated with episo-
J Behav Med (2017) 40:875–885 879
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dic stress prior to diagnosis (r = .16, p\ .01) and with
episodic stress between diagnosis and study entry (r = .14,
p\ .01). Chronic stress at study entry was moderately
correlated with symptom bother throughout the study per-
iod (range: r = .25–.37, all ps\ .001). Episodic stress pre-
diagnosis was not significantly related to episodic stress
shortly after diagnosis, and was significantly but weakly
correlated with symptom bother at nearly all assessments
(range: r = .11–.16, all ps\ .05, except p = .07 at
24 weeks). Episodic stress shortly after diagnosis was
significantly related to symptom bother at all assessments
(range: r = .11–.24, all ps\ .05).
Table 1 Cancer- and treatment-related variables (N = 460)
Variable Study entry
M (SD)/n (%)
6 weeks
M (SD)/n (%)
12 weeks
M (SD)/n (%)
18 weeks
M (SD)/n (%)
24 weeks
M (SD)/n (%)
9 months
M (SD)/n (%)
12 months
M (SD)/n (%)
Months since diagnosis 2.13 (.8) 3.79 (1.0) 5.21 (1.1) 6.54 (1.0) 7.99 (1.0) 11.47 (1.0) 14.6 (1.0)
Stage
1 197 (43.8)
2 176 (39.1)
3 52 (11.6)
4 25 (5.6)
Chemotherapy in past 6 weeks 183 (41.7) 167 (42.3) 110 (28.4) 53 (13.8) 27 (7.0) 11 (2.8) 5 (1.4)
Radiation therapy in past 6 weeks 31 (7.0) 35 (8.9) 19 (4.5) 44 (11.5) 39 (10.1) 13 (3.4) 2 (.5)
Surgery in past 6 weeks 270 (59.6) 57 (14.4) 43 (11.1) 59 (15.4) 48 (12.5) 47 (12.1) 30 (8.2)
Taking estrogen antagonist 30 (6.6) 45 (11.5) 53 (13.8) 67 (17.5) 85 (22.1) 124 (32.1) 110 (30.1)
Taking aromatase inhibitor 37 (8.2) 64 (16.3) 71 (18.4) 75 (19.6) 79 (20.6) 108 (28.0) 112 (30.7)
Taking herceptin 72 (15.9) 75 (19.1) 80 (20.7) 82 (21.4) 79 (20.5) 82 (21.2) 42 (11.4)
Completed treatment since
most recent assessment
112 (24.5) 54 (11.8) 48 (10.5) 75 (16.4) 85 (18.6) 47 (10.3) 36 (7.9)
Table 2 Correlations between major variables at each assessment point
Variable M (SD) 2 3 4 5 6 7 8 9 10
1. Study entry chronic stress 2.25 (.39) .16** .14** .25*** .29*** .35*** .31*** .34*** .34*** .37***
2. Pre-diagnosis episodic stress 1.43 (2.07) – .08 .16** .12* .15** .11* .09 .16** .12*
3. Post-diagnosis episodic stress .63 (1.35) – .21*** .24*** .22*** .11* .19*** .20*** .24***
4. Study entry BCPT .83 (.50) – .71*** .69*** .63*** .58*** .61*** .57***
5. 6-week BCPT .80 (.46) – .77*** .72*** .63*** .65*** .59***
6. 12-week BCPT .85 (.50) – .80*** .73*** .67*** .63***
7. 18-week BCPT .79 (.48) – .80*** .67*** .63***
8. 24-week BCPT .76 (.48) – .73*** .72***
9. 9-month BCPT .71 (.49) – .81***
10. 12-month BCPT .67 (.47) –
BCPT Breast Cancer Prevention Trial Symptom Scale
* p\ .05, ** p\ .01, *** p\ .001
Table 3 Correlations between stress variables at study entry and 9 months
Variable M (SD) 2 3 4 5
1. Study entry chronic stress 2.25 (.39) .16** .14** .92*** .13**
2. Pre-diagnosis episodic stress 1.43 (2.07) – .08 .16** .17**
3. Post-diagnosis episodic stress .63 (1.35) – .17** .32***
4. 9-month chronic stress 2.28 (.40) – .21***
5. 9-month episodic stress 1.88 (2.50) –
* p\ .05, ** p\ .01, *** p\ .001
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Chronic stress ratings at study entry and the 9-month
assessment were highly correlated (r = .92, p\ .001).
There was a small but significant correlation between
episodic stress pre-diagnosis and at 9 months (r = .17,
p\ .01) and a moderate correlation between episodic
stress shortly after diagnosis and at 9 months (r = .32,
p\ .001).
Overall physical symptom trajectory
In the 12 months following study entry, on average, the
overall symptom trajectory (see Fig. 1) remained constant
during the first few months (linear: b = -.06, p = .07) and
decreased thereafter (quadratic: b = -.34, p\ .001).
Deviance change tests revealed significantly better model
fit when random intercept (v2 (1) = 45.95, p\ .001),
random linear (v2 (2) = 785.19, p\ .001), and random
quadratic (v2 (3) = 26.16, p\ .001) terms were included,
indicating significant differences in intercepts, linear
trends, and quadratic trends across women.
Covariates
When MSEM models were used to test the univariate
effects of each potential covariate on symptom bother, no
significant relationships emerged for ethnicity, education,
body mass index, perceived social status, physical comor-
bidities, or surgery. Compared with employment, unem-
ployment and retirement were each associated with higher
symptom bother across time (b = .24, p\ .001 and
b = .06, p\ .001, respectively), as was more advanced
cancer stage (b = .05, p\ .05). Linear and quadratic time
trends for these variables were nonsignificant.
Age, marital status, income, radiation, herceptin use,
and assessment at which last treatment occurred were
related to the linear, but not the quadratic, time trend.
Younger age was associated with greater symptom bother
at study entry, and the effect became larger over time
(intercept: b = -.01, p\ .001, linear: b = .01, p\ .01).
Married women, women with higher incomes, women
prescribed herceptin, and women who completed oncologic
treatment later reported higher symptom bother at study
entry, and the effect became smaller over time (intercept:
b = .14, p\ .01, linear: b = -.14, p\ .01 for marital
status; intercept: b = .08, p\ .001, linear: b = -.06,
p\ .01 for income; intercept: b = .13, p\ .01, linear:
b = -.16, p\ .05 for herceptin; intercept: b = .07,
p\ .001, linear: b = -.02, p\ .05 for later treatment
completion). Radiation was related to less symptom bother
at study entry, and the effect became larger over time
(intercept: b = -.11, p\ .01, linear: b = .18, p\ .05).
Study site, chemotherapy, and endocrine therapy pre-
dicted the quadratic time trajectory. Participants in Cali-
fornia reported greater symptom bother at study entry, and
the effect decreased more quickly than for those in Arizona
and leveled off (intercept: b = .28, p\ .001, linear:
b = -.27, p\ .05, quadratic: b = .32, p\ .01). Che-
motherapy was not related to symptom bother at study
entry, but linear and quadratic time trends were significant
(linear: b = .34, p\ .05, quadratic: b = -.49, p\ .05).
Endocrine therapy was not related to the intercept or linear
time trend, but the quadratic time trend was significant
(b = .19, p\ .05).
Next, a multivariate model was tested. In the multi-
variate model, ethnicity did not significantly predict the
intercept or linear time trend, but Latina ethnicity was
related to an increasing escalation in symptom bother over
time (quadratic: b = .33, p\ .05). Number of comorbidi-
ties was associated with greater symptom bother at study
entry (b = .06, p\ .001); linear and quadratic time trends
were not significant. Ethnicity (with quadratic and linear
time trends) and comorbidities were added to the final
covariate model. Education, perceived social status, body
mass index, and surgery remained nonsignificant in mul-
tivariate analyses and were not included in subsequent
models. See Table 4 for all variables included in the final
model.
Effects of chronic and episodic stress on physical
symptom bother
Study entry chronic stress predicted the BCPT intercept
(b = .34, p\ .001) and not the linear or quadratic time
trajectory, indicating that women with higher chronic stress
at study entry reported significantly greater physical
symptom bother across assessments (see Table 4). Effect
size estimates indicate that the addition of chronic stress to
a model with covariates resulted in a 9% reduction in
Fig. 1 Overall mean symptom trajectory for Breast Cancer Prevention
Trial Symptom Scale
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Table 4 Longitudinal growth models of physical symptom bother (BCPT) association with chronic and episodic stress
Variable Study entry
chronic stress
Post-diagnosis
episodic stress
Chronic stress and
post-diagnosis
episodic stress
Chronic stress and
pre-diagnosis
episodic stress
Est. (SE) Est. (SE) Est. (SE) Est. (SE)
Intercept
Intercept .74*** (.13) .84*** (.14) .74*** (.13) .74*** (.13)
Age -.01** (.00) -.01*** (.00) -.01** (.00) -.01** (.00)
Married (ref = no) .09* (.04) .07 (.04) .09* (.04) .09* (.04)
Ethnicity (ref = non-Latina white) .05 (.06) .05 (.06) .05 (.06) .05 (.06)
Income .06*** (.02) .04* (.02) .06*** (.02) .06** (.02)
Employment (ref = employed)
Retired -.05 (.05) -.09 (.05) -.05 (.05) -.05 (.05)
Unemployed .16*** (.05) .17** (.05) .16** (.05) .16*** (.05)
Physical comorbidities .04*** (.01) .05*** (.01) .04*** (.01) .04*** (.01)
Site (ref = Arizona) .17*** (.04) .16*** (.04) .15** (.04) .34*** (.05)
Stage .01 (.02) .00 (.02) .01 (.02) .01 (.02)
Chemotherapya (ref = no) -.01 (.03) -.01 (.03) -.01 (.03) -.01 (.03)
Radiationa (ref = no) -.08* (.03) -.09* (.03) -.08* (.03) -.08* (.03)
Herceptina (ref = no) .07 (.04) .06 (.04) .07 (.04) .07 (.04)
Endocrine therapya (ref = no) -.00 (.03) -.00 (.03) -.00 (.03) -.00 (.03)
Last treatment .02* (.01) .03* (.01) .02* (.01) .02* (.01)
Study entry chronic stress .34*** (.05) – .33*** (.05) .34*** (.05)
Post-diagnosis episodic stress – .04** (.01) .03* (.01) –
Pre-diagnosis episodic stress – – – .01 (.01)
Linear trajectory
Intercept .07 (.17) .07 (.17) .07 (.17) .07 (.17)
Age .00* (.00) .00* (.00) .00* (.00) .00* (.00)
Married (ref = no) -.07 (.04) -.07 (.04) -.07 (.04) -.07 (.04)
Ethnicity (ref = non-Latina white) -.29 (.17) -.30 (.17) -.23 (.17) -.29 (.17)
Income -.05** (.02) -.05** (.02) -.05** (.02) -.05** (.02)
Site -.19 (.12) -.19 (.12) -.19 (.12) -.19 (.12)
Last treatment -.01 (.01) -.01 (.01) -.01 (.01) -.01 (.01)
Chemotherapya (ref = no) .43** (.17) .43** (.17) .42* (.16) .43** (.17)
Radiationa (ref = no) .14 (.08) .15 (.08) .14 (.08) .14 (.08)
Herceptina (ref = no) -.08 (.06) -.07 (.06) -.08 (.06) -.08 (.06)
Endocrine therapya (ref = no) -.08 (.12) -.10 (.12) -.09 (.12) -.08 (.12)
Quadratic trajectory
Intercept -.41*** (.11) -.41*** (.11) -.41*** (.11) -.41*** (.11)
Ethnicity (ref = non-Latina white) .38** (.15) .38** (.15) .38* (.15) .34** (.15)
Site .33** (.11) .33** (.11) .33** (.11) .33** (.11)
Chemotherapya (ref = no) -.54* (.23) -.55* (.24) -.53* (.23) -.54* (.23)
Endocrine therapya (ref = no) .15 (.10) .16 (.10) .15 (.10) .15 (.10)
Pre-diagnosis episodic stress was reported by participants at study entry and was not a significant predictor of BCPT; interactions between
chronic stress and episodic stress pre- and post-diagnosis also were not significant predictors of BCPT (longitudinal growth models not shown)
Est. = regression coefficient; SE standard error; BCPT Breast Cancer Prevention Trial Symptom Scale
* p\ .05. ** p\ .01. *** p\ .001
a Indicates variable is time-varying, all other variables are time-invarying
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residual variance of the Level 2 intercept (R2 = .09). Post-
diagnosis episodic stress predicted the BCPT intercept
(b = .04, p\ .01) and not the linear or quadratic time
trajectory, such that women with higher episodic stress
shortly after diagnosis reported significantly greater
symptom bother across time. The addition of post-diag-
nosis episodic stress to a model with covariates resulted in
a 2% reduction in residual variance of the Level 2 intercept
(R2 = .02). Episodic stress prior to breast cancer diagnosis
did not significantly predict the intercept or the linear or
quadratic time trajectory.
With chronic stress and post-diagnosis episodic stress in
the same model, significant main effects of both chronic
stress (b = .33, p\ .001) and post-diagnosis episodic
stress (b = .03, p\ .05) emerged on symptom bother (see
Table 4). Higher levels of both types of stress were sig-
nificantly related to greater symptom bother over time.
Neither of these stress measures predicted the linear or
quadratic time trajectory. The addition of chronic stress
and post-diagnosis episodic stress to a model with only
covariates resulted in a 10% reduction in residual variance
of the Level 2 intercept (R2 = .10). With chronic stress and
pre-diagnosis episodic stress in the same model, there was
a significant main effect of chronic stress on symptom
bother (b = .34, p\ .001); pre-diagnosis episodic stress
was not significantly related to symptom bother, and nei-
ther stress measure predicted the linear or quadratic time
trajectory. Interactions between chronic stress and pre-di-
agnosis episodic stress and between chronic stress and
post-diagnosis episodic stress did not predict the intercept
or the linear or quadratic time trajectory.
Discussion
As hypothesized, both chronic stress and episodic stress
during the first months after breast cancer diagnosis pre-
dicted greater physical symptom bother throughout the
following year. Episodic stress reported to have occurred in
the 6 months prior to diagnosis was unrelated to symptom
bother. Contrary to expectation, no significant interactions
emerged between chronic and episodic stress on symptom
bother. Instead, when examined in the same model, both
chronic and post-diagnosis episodic stress emerged as
unique predictors of subsequent bothersome physical
symptoms. These results suggest that stressful life events
occurring in the context of ongoing chronic stress have a
unique rather than a multiplicative association with future
bothersome physical symptoms.
Our findings are consistent with the biobehavioral model
of cancer stress and disease (Andersen et al., 1994) and
empirical evidence suggesting that life stress negatively
influences adjustment to cancer (Burgess et al., 2005;
Golden-Kreutz et al., 2005; Golden-Kreutz & Andersen,
2004; Grassi et al., 1997; Kornblith et al., 2001). To our
knowledge, only one previous study (Golden-Kreutz et al.,
2005) examined life stress as a predictor of physical health-
related adjustment to breast cancer. In that study, stressful
life events prior to diagnosis and perceived overall and
cancer-related stress after initial surgery for breast cancer
predicted poorer physical health-related quality of life
during and after adjuvant treatment.
Findings from the current study add to the knowledge
base by elucidating the relative influences of chronic and
episodic stress on bothersome physical symptoms in breast
cancer. When examined in the same model, chronic and
post-diagnosis episodic stress each remained significant
predictors of physical symptom bother. Calculations of
unique effect sizes of each type of stress suggest that
chronic stress is a stronger predictor of physical symptom
bother than post-diagnosis episodic stress. Chronic stress
accounted for an additional 8% of variance when added to
a model with post-diagnosis episodic stress and covariates,
whereas post-diagnosis episodic stress added 1% of vari-
ance to a model with chronic stress and covariates.
Whereas episodic stress occurring shortly after diagno-
sis (between diagnosis and study entry, a period of
approximately 2 months) predicted bothersome physical
symptoms over time, stressful life events reported to have
occurred during the 6 months prior to diagnosis were
unrelated to symptom bother. These results are consistent
with research on the time-limited effects of episodic
stressors (Suh et al., 1996). Prior to diagnosis, women may
be better equipped to cope with, and perhaps resolve,
stressful life events. The period shortly after diagnosis,
however, presents many challenges that may preclude
effective management and resolution of stressors. After
breast cancer diagnosis, women often must make difficult
treatment-related decisions and plan for changes in
employment and other life roles (Holland et al., 2015).
During this time, coping with additional stressors such as a
family member’s illness or a financial hardship may be
particularly trying. Indeed, results of the current study
suggest that stressful life events occurring shortly after
diagnosis have a lasting impact on physical symptom
bother throughout the following year. Another possible
explanation for the lasting impact of episodic stress
occurring shortly after diagnosis is that women who
experience stressful life events at study entry are more
likely to experience additional events during the follow-up
period. Severity ratings for episodic stress during the
approximately 8 months prior to study entry and the sub-
sequent 9 months, however, were only weakly correlated.
How does life stress affect cancer-related physical symp-
toms such as pain and fatigue? Although the current study did
not examine mediators of this relationship, the biobehavioral
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model of cancer stress and disease (Andersen et al., 1994)
describes plausible mechanisms. Stressful life events and
longer-term chronic stressors are associated with decrements
in immune functioning (Herbert & Cohen, 1993), which may
influence treatment response and treatment-related side
effects. Stress may also negatively affect health behaviors
such as diet, physical activity, and alcohol use; for cancer
patients, unhealthy behaviors may have important conse-
quences for physical health-related adjustment (Andersen
et al., 1994). Themodel of conservation of resources (Hobfoll,
1989) offers another useful lens throughwhich to consider the
effects of stress on treatment-related side effects. Women
experiencing chronic stress and recent episodic stressors may
have depleted psychological (e.g., mastery, self-esteem),
social, and material resources to cope effectively with the
cancer diagnosis, and therefore may experience more distress
related to side effects of treatment. Indeed, one study found
that, among women with breast cancer who had recently
completed primary oncologic treatment, cancer-related
emotional approach coping (i.e., coping through emotional
processing and expression) was adaptive only under condi-
tions of low stress (Low et al., 2006). Depression may also
mediate the effects of life stress on bothersome physical
symptoms (Hammen, 2005). Future research is needed to test
these and other possible mechanisms.
Strengths and limitations
This study has a number of strengths. In a relatively large
sample of women newly diagnosed with breast cancer,
physical symptombotherwas assessed longitudinally, which
allowed for characterization of relations among life stress
and bothersome symptoms over time. Whereas previous
studies have employed self-report measures of perceived
overall stress (Golden-Kreutz et al., 2005; Golden-Kreutz &
Andersen, 2004) and/or life events checklists to assess the
occurrence or impact of stressful life events (Golden-Kreutz
et al., 2005; Golden-Kreutz & Andersen, 2004; Grassi et al.,
1997; Kornblith et al., 2001; Low et al., 2006), the present
study used a detailed interview to obtain a comprehensive
assessment of the severity of chronic stress in various life
domains and the impact of stressful life events based on the
context in which the events occurred.
Discussion of study limitations is warranted. On aver-
age, women in the current study were younger
(M = 56.4 years) than the population median age of breast
cancer diagnosis of 61 years (American Cancer Society,
2015). Although the ethnic makeup in the study reflected
local recruitment populations, African American women
were under-represented and Latinas were over-represented
relative to the breast cancer population in the U.S. There-
fore, the findings cannot by generalized to diverse groups
without further examination.
Conclusions and future directions
Our findings suggest that ongoing chronic stress and epi-
sodic stress occurring shortly after breast cancer diagnosis
are important and unique predictors of persistent and
bothersome physical symptoms during and after breast
cancer treatment. Screening in the months after diagnosis
for ongoing chronic stress and recent stressful life events
may help identify women at risk for experiencing distress
related to physical symptoms during and after treatment.
Patients experiencing stress during cancer may have fewer
resources to cope with ongoing physical symptoms and, as
such, are especially likely to benefit from careful attention
to symptom management by their clinicians. Furthermore,
findings suggest that interventions to prevent or ameliorate
bothersome cancer-related physical symptoms should
begin soon after breast cancer diagnosis and might be more
effective if they address ongoing non-cancer-related stress
in women’s lives. This work advances knowledge regard-
ing the role of life stress in adjustment to cancer and
informs applied research that aims to identify at-risk
women recently diagnosed with breast cancer for timely
intervention.
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